JaDera Diet Pills: Unveiling the Hidden Dangers and Ingredients

The allure of rapid weight loss often leads individuals to explore various dietary supplements. Among these, JaDera diet pills have gained attention, but not without raising serious concerns. This article delves into the ingredients of JaDera diet pills, the associated risks, and the regulatory actions taken against them.

The JaDera Recall: A Response to Hidden Ingredients

Dolphin Intertrade Corp. of Miami, Florida, initiated a voluntary recall of both "JaDera" and "Xiyouji Qingzhi" Weight Loss Supplements. This action stemmed from the discovery of a concerning ingredient: Sibutramine.

Sibutramine poses a threat to consumers because it is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. These products may also interact in life threatening ways with other medications a consumer may be taking.

Sibutramine: A Risk to Cardiovascular Health

Sibutramine, a controlled substance, was previously used as an appetite suppressant but was removed from the market in October 2010 due to safety concerns. Its presence in JaDera diet pills raises significant health risks.

Sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.

Read also: The Hoxsey Diet

The inclusion of sibutramine in JaDera diet pills poses a serious threat to individuals with pre-existing cardiovascular conditions.

JaDera PLUS: The Deceptive Marketing of Harmful Substances

The Food and Drug Administration (FDA) issued a warning to consumers, advising against the purchase or use of JaDera PLUS, a product marketed for weight loss. FDA laboratory analysis confirmed that JaDera PLUS contains sibutramine, N-desmethylsibutramine, and benproperine.

N-desmethylsibutramine is a substance structurally similar to sibutramine, further compounding the potential health risks.

Product Details and Distribution

JaDera Weight Loss Supplement is marketed as a dietary supplement used as a weight loss aid and is packaged in bottles of # 30 capsules. The affected JaDera Weight Loss Supplement, includes manufactured lot 10.06.2011 with Expiration Date: 09.06.2013. JaDera Weight Loss Supplement was distributed Nationwide to consumers and distributors. Xiyouji Qingzhi Weight Loss Supplement is marketed as a dietary supplement used as a weight loss aid and is packaged in bottles of # 30 capsules of 300mg. The affected Xiyouji Qingzhi Weight Loss Supplement, includes all lots.

The FDA's Stance on Hidden Ingredients

The FDA is actively working to inform the public about products marketed as dietary supplements or conventional foods with hidden drug ingredients and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients.

Read also: Walnut Keto Guide

Read also: Weight Loss with Low-FODMAP

tags: #jadera #diet #pills #ingredients